SIMILAR PATTERNS OF AMINO ACIDS FOR 3NDX_A_RITA100_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bqc PROTEIN
(BETA-MANNANASE)


(Thermobifida
fusca)
PF00150
(Cellulase)
5 GLY A 227
ILE A 195
GLY A 224
ILE A 252
ILE A 240
None
0.85A 3ndxB-1bqcA:
undetectable
3ndxB-1bqcA:
16.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 (-3.6A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.50A 3ndxB-1hvcA:
13.9
3ndxB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 (-3.4A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.48A 3ndxB-1hvcA:
13.9
3ndxB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 (-3.6A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.42A 3ndxB-1hvcA:
13.9
3ndxB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A  87
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  50
None
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.8A)
1.44A 3ndxB-1hvcA:
13.9
3ndxB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A  87
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  50
None
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.0A)
1.47A 3ndxB-1hvcA:
13.9
3ndxB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.78A 3ndxB-1hvcA:
13.9
3ndxB-1hvcA:
46.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 (-4.1A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.82A 3ndxB-1hvcA:
13.9
3ndxB-1hvcA:
46.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l5j ACONITATE HYDRATASE
2


(Escherichia
coli)
PF00330
(Aconitase)
PF06434
(Aconitase_2_N)
PF11791
(Aconitase_B_N)
5 GLY A 721
ALA A 720
GLY A 715
ILE A 714
ILE A 707
None
0.78A 3ndxB-1l5jA:
undetectable
3ndxB-1l5jA:
9.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1llu ALCOHOL
DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A  42
ILE A  64
GLY A 119
VAL A  36
ILE A  38
None
0.89A 3ndxB-1lluA:
undetectable
3ndxB-1lluA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mew INOSINE-5'-MONOPHOSP
HATE DEHYDROGENASE


(Tritrichomonas
suis)
PF00478
(IMPDH)
PF00571
(CBS)
5 GLY A 288
ASP A 261
GLY A 235
VAL A 247
ILE A 238
None
NAD  A 987 (-2.5A)
None
None
None
0.90A 3ndxB-1mewA:
undetectable
3ndxB-1mewA:
12.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
None
0.58A 3ndxB-1q9pA:
9.9
3ndxB-1q9pA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rvv RIBOFLAVIN SYNTHASE

(Bacillus
subtilis)
no annotation 6 GLY A  33
ALA A  34
ILE A 112
GLY A 114
VAL A  50
ILE A  17
None
1.40A 3ndxB-1rvvA:
undetectable
3ndxB-1rvvA:
26.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.39A 3ndxB-1sivA:
18.2
3ndxB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
0.55A 3ndxB-1sivA:
18.2
3ndxB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
None
0.76A 3ndxB-1sivA:
18.2
3ndxB-1sivA:
51.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tjr BX1

(Zea mays)
PF00290
(Trp_syntA)
5 GLY A 307
ALA A 308
ASP A 309
VAL A 269
ILE A 303
None
0.82A 3ndxB-1tjrA:
undetectable
3ndxB-1tjrA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to3 PUTATIVE ALDOLASE
YIHT


(Salmonella
enterica)
PF01791
(DeoC)
5 GLY A 188
ALA A 189
ASP A 190
VAL A 127
ILE A 158
None
0.73A 3ndxB-1to3A:
undetectable
3ndxB-1to3A:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ywf PHOSPHOTYROSINE
PROTEIN PHOSPHATASE
PTPB


(Mycobacterium
tuberculosis)
PF13350
(Y_phosphatase3)
6 GLY A 261
ALA A 260
ASP A 259
ILE A 246
GLY A 254
VAL A 174
None
1.17A 3ndxB-1ywfA:
undetectable
3ndxB-1ywfA:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zap SECRETED ASPARTIC
PROTEINASE


(Candida
albicans)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
GLY A  83
ILE A 123
A70  A 500 ( 2.7A)
A70  A 500 (-3.8A)
None
None
A70  A 500 (-4.8A)
0.78A 3ndxB-1zapA:
7.2
3ndxB-1zapA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.87A 3ndxB-2bc0A:
undetectable
3ndxB-2bc0A:
12.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bws XAA-PRO
AMINOPEPTIDASE P


(Escherichia
coli)
PF00557
(Peptidase_M24)
PF05195
(AMP_N)
5 ARG A 221
GLY A 262
ALA A 261
ASP A 260
ILE A 215
None
None
None
MN  A1442 (-2.0A)
None
0.87A 3ndxB-2bwsA:
undetectable
3ndxB-2bwsA:
13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2byg CHANNEL ASSOCIATED
PROTEIN OF
SYNAPSE-110


(Homo sapiens)
PF00595
(PDZ)
6 GLY A 231
ALA A 233
ASP A 236
ILE A 194
VAL A 241
ILE A 227
None
1.49A 3ndxB-2bygA:
undetectable
3ndxB-2bygA:
21.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
ILE A  89
LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.56A 3ndxB-2fmbA:
15.2
3ndxB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
GLY A  54
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.72A 3ndxB-2fmbA:
15.2
3ndxB-2fmbA:
33.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ilu ALDEHYDE
DEHYDROGENASE A


(Escherichia
coli)
PF00171
(Aldedh)
6 ALA A  46
ASP A  45
ILE A  11
ILE A 175
VAL A 145
ILE A  50
None
1.34A 3ndxB-2iluA:
undetectable
3ndxB-2iluA:
14.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.80A 3ndxB-2rkfA:
20.5
3ndxB-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
AB1  A 501 ( 4.7A)
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 ( 4.2A)
0.47A 3ndxB-2rkfA:
20.5
3ndxB-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 ARG A  10
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
0.86A 3ndxB-2rspA:
12.7
3ndxB-2rspA:
33.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 ARG A 105
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
1.48A 3ndxB-2rspA:
12.7
3ndxB-2rspA:
33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2uv8 FATTY ACID SYNTHASE
SUBUNIT BETA (FAS1)


(Saccharomyces
cerevisiae)
PF00698
(Acyl_transf_1)
PF01575
(MaoC_dehydratas)
PF08354
(DUF1729)
PF13452
(MaoC_dehydrat_N)
PF16073
(SAT)
5 GLY G 621
ALA G 620
ILE G 617
GLY G 648
ILE G 676
None
FMN  G3051 ( 4.7A)
None
None
None
0.90A 3ndxB-2uv8G:
undetectable
3ndxB-2uv8G:
4.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2va8 SKI2-TYPE HELICASE

(Sulfolobus
solfataricus)
PF00270
(DEAD)
PF00271
(Helicase_C)
5 ALA A 233
ASP A 232
GLY A 355
ILE A 354
VAL A 404
None
0.90A 3ndxB-2va8A:
undetectable
3ndxB-2va8A:
9.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y23 MYOMESIN

(Homo sapiens)
PF07679
(I-set)
5 ASP A1401
GLY A1409
ILE A1410
VAL A1428
ILE A1389
None
0.87A 3ndxB-2y23A:
undetectable
3ndxB-2y23A:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z0j PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA1438


(Thermus
thermophilus)
PF04029
(2-ph_phosp)
5 ARG A 129
GLY A 156
ALA A 155
GLY A 173
VAL A 136
None
0.86A 3ndxB-2z0jA:
undetectable
3ndxB-2z0jA:
15.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zc0 ALANINE GLYOXYLATE
TRANSAMINASE


(Thermococcus
litoralis)
PF00155
(Aminotran_1_2)
6 GLY A 243
ALA A 242
ASP A 214
ILE A 105
VAL A 268
ILE A 258
None
None
PMP  A 409 (-2.7A)
None
None
None
1.49A 3ndxB-2zc0A:
undetectable
3ndxB-2zc0A:
14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3abi PUTATIVE
UNCHARACTERIZED
PROTEIN PH1688


(Pyrococcus
horikoshii)
PF03435
(Sacchrp_dh_NADP)
PF16653
(Sacchrp_dh_C)
6 ARG A 342
GLY A 117
ALA A 116
ASP A 115
GLY A  67
ILE A 306
None
NAD  A1001 (-3.6A)
None
None
None
None
1.23A 3ndxB-3abiA:
undetectable
3ndxB-3abiA:
11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqc COMPONENT B OF
HEXAPRENYL
DIPHOSPHATE SYNTHASE


(Micrococcus
luteus)
PF00348
(polyprenyl_synt)
5 ASP B 211
ASP B 212
ILE B 167
GLY B 204
ILE B 203
MG  B 328 (-3.1A)
None
None
None
None
0.84A 3ndxB-3aqcB:
undetectable
3ndxB-3aqcB:
18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqp PROBABLE SECDF
PROTEIN-EXPORT
MEMBRANE PROTEIN


(Thermus
thermophilus)
PF02355
(SecD_SecF)
PF07549
(Sec_GG)
5 GLY A 327
ALA A 329
GLY A 274
ILE A 271
VAL A 693
None
0.81A 3ndxB-3aqpA:
undetectable
3ndxB-3aqpA:
10.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dfy MUCONATE
CYCLOISOMERASE


(Thermotoga
maritima)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 ASP A 188
GLY A 291
ILE A 290
VAL A 157
ILE A 186
MG  A 401 (-2.7A)
None
None
None
None
0.78A 3ndxB-3dfyA:
undetectable
3ndxB-3dfyA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3egj N-ACETYLGLUCOSAMINE-
6-PHOSPHATE
DEACETYLASE


(Vibrio cholerae)
PF01979
(Amidohydro_1)
5 GLY A 241
ALA A 240
ILE A 260
VAL A 228
ILE A 232
None
0.88A 3ndxB-3egjA:
undetectable
3ndxB-3egjA:
15.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3er6 PUTATIVE
TRANSCRIPTIONAL
REGULATOR PROTEIN


(Vibrio
parahaemolyticus)
PF01965
(DJ-1_PfpI)
5 GLY A 125
ALA A 124
ILE A  93
ILE A 118
ILE A 101
None
0.87A 3ndxB-3er6A:
undetectable
3ndxB-3er6A:
19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fbs OXIDOREDUCTASE

(Agrobacterium
fabrum)
PF07992
(Pyr_redox_2)
5 GLY A 284
ALA A  17
ILE A  66
GLY A  22
ILE A   7
None
0.86A 3ndxB-3fbsA:
undetectable
3ndxB-3fbsA:
17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fkj PUTATIVE
PHOSPHOSUGAR
ISOMERASES


(Salmonella
enterica)
PF01380
(SIS)
5 ALA A  99
ILE A  75
GLY A 102
ILE A 118
ILE A  15
None
0.88A 3ndxB-3fkjA:
undetectable
3ndxB-3fkjA:
13.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fsx TETRAHYDRODIPICOLINA
TE
N-SUCCINYLTRANSFERAS
E


(Mycobacterium
tuberculosis)
PF14602
(Hexapep_2)
PF14789
(THDPS_M)
6 ARG A  95
ALA A 165
ASP A 166
ASP A 164
VAL A 160
ILE A 162
MPD  A 340 (-3.9A)
None
NA  A 334 ( 3.7A)
NA  A 334 (-3.3A)
None
None
1.46A 3ndxB-3fsxA:
undetectable
3ndxB-3fsxA:
15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gt7 SENSOR PROTEIN

(Syntrophus
aciditrophicus)
PF00072
(Response_reg)
6 ARG A 102
GLY A 107
ALA A 108
ASP A 109
ILE A  59
VAL A  63
None
1.15A 3ndxB-3gt7A:
undetectable
3ndxB-3gt7A:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
5 GLY A 121
ALA A 122
ASP A 123
ILE A  89
ILE A 126
None
0.76A 3ndxB-3gveA:
undetectable
3ndxB-3gveA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hn6 GLUCOSAMINE-6-PHOSPH
ATE DEAMINASE


(Borreliella
burgdorferi)
PF01182
(Glucosamine_iso)
5 GLY A 139
ILE A 193
GLY A 136
ILE A 202
ILE A 226
None
0.85A 3ndxB-3hn6A:
undetectable
3ndxB-3hn6A:
18.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
6 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
ILE A 224
None
1.04A 3ndxB-3i5gA:
undetectable
3ndxB-3i5gA:
8.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iay DNA POLYMERASE DELTA
CATALYTIC SUBUNIT


(Saccharomyces
cerevisiae)
PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1)
5 ASP A 976
GLY A 975
ALA A 971
ILE A 811
GLY A 598
None
0.75A 3ndxB-3iayA:
undetectable
3ndxB-3iayA:
8.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ic9 DIHYDROLIPOAMIDE
DEHYDROGENASE


(Colwellia
psychrerythraea)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
6 ARG A 344
ASP A 324
GLY A 309
ALA A 308
ILE A  10
GLY A  14
None
NA  A 491 (-3.0A)
FAD  A 490 ( 3.3A)
None
None
FAD  A 490 (-3.2A)
1.32A 3ndxB-3ic9A:
undetectable
3ndxB-3ic9A:
10.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
None
0.68A 3ndxB-3mwsA:
19.7
3ndxB-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
VAL A  82
ILE A  84
None
0.84A 3ndxB-3mwsA:
19.7
3ndxB-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
GLY A  48
VAL A  82
ILE A  84
None
1.45A 3ndxB-3mwsA:
19.7
3ndxB-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
VAL A  82
ILE A  84
None
0.72A 3ndxB-3mwsA:
19.7
3ndxB-3mwsA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
None
0.53A 3ndxB-3mwsA:
19.7
3ndxB-3mwsA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8l 6-PHOSPHOFRUCTOKINAS
E, MUSCLE TYPE


(Oryctolagus
cuniculus)
PF00365
(PFK)
5 GLY A 224
ALA A 225
ASP A 226
VAL A 207
ILE A 261
PO4  A 767 ( 4.6A)
None
None
None
None
0.82A 3ndxB-3o8lA:
undetectable
3ndxB-3o8lA:
9.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ogz UDP-SUGAR
PYROPHOSPHORYLASE


(Leishmania
major)
PF01704
(UDPGP)
5 GLY A 122
ALA A 121
ASP A 271
ILE A 269
ILE A 167
None
0.88A 3ndxB-3ogzA:
undetectable
3ndxB-3ogzA:
10.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opy 6-PHOSPHOFRUCTO-1-KI
NASE ALPHA-SUBUNIT


(Komagataella
pastoris)
PF00365
(PFK)
5 GLY A 419
ALA A 420
ASP A 421
VAL A 402
ILE A 457
None
0.80A 3ndxB-3opyA:
undetectable
3ndxB-3opyA:
7.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE


(Corynebacterium
glutamicum)
PF00171
(Aldedh)
5 GLY A 285
ALA A 286
ILE A 389
VAL A 396
ILE A 394
GLY  A 285 ( 0.0A)
ALA  A 286 ( 0.0A)
ILE  A 389 ( 0.7A)
VAL  A 396 ( 0.6A)
ILE  A 394 ( 0.7A)
0.88A 3ndxB-3r64A:
undetectable
3ndxB-3r64A:
11.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s2g ZINC-CONTAINING
ALCOHOL
DEHYDROGENASE
SUPERFAMILY


(Cupriavidus
pinatubonensis)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A  40
ILE A  62
GLY A 117
VAL A  34
ILE A  36
None
0.88A 3ndxB-3s2gA:
undetectable
3ndxB-3s2gA:
16.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.53A 3ndxB-3t3cA:
18.4
3ndxB-3t3cA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
None
017  A 201 (-4.7A)
0.79A 3ndxB-3ttpA:
19.2
3ndxB-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
017  A 201 ( 4.8A)
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-4.7A)
0.53A 3ndxB-3ttpA:
19.2
3ndxB-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.7A)
0.62A 3ndxB-3ttpA:
19.2
3ndxB-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.58A 3ndxB-3u7sA:
19.5
3ndxB-3u7sA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
None
0.59A 3ndxB-3uhlA:
16.3
3ndxB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
None
0.38A 3ndxB-3uhlA:
16.3
3ndxB-3uhlA:
80.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zyy IRON-SULFUR CLUSTER
BINDING PROTEIN


(Carboxydothermus
hydrogenoformans)
PF00111
(Fer2)
PF14574
(DUF4445)
5 GLY X 577
ALA X 578
ILE X 345
GLY X 355
ILE X 357
None
0.88A 3ndxB-3zyyX:
undetectable
3ndxB-3zyyX:
11.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a69 HISTONE DEACETYLASE
3,


(Homo sapiens)
PF00850
(Hist_deacetyl)
5 GLY A 267
ILE A 346
GLY A 226
ILE A 227
VAL A 342
None
0.88A 3ndxB-4a69A:
undetectable
3ndxB-4a69A:
12.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aa9 CHYMOSIN

(Camelus
dromedarius)
PF00026
(Asp)
5 ASP A  34
GLY A  36
ASP A  39
ILE A  75
ILE A 122
None
None
None
SO4  A1332 (-4.4A)
None
0.89A 3ndxB-4aa9A:
8.2
3ndxB-4aa9A:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d10 COP9 SIGNALOSOME
COMPLEX SUBUNIT 3


(Homo sapiens)
PF01399
(PCI)
6 ALA C 127
ASP C 129
GLY C 122
ILE C 121
VAL C  81
ILE C  85
None
1.30A 3ndxB-4d10C:
undetectable
3ndxB-4d10C:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g09 HISTIDINOL
DEHYDROGENASE


(Brucella suis)
PF00815
(Histidinol_dh)
6 ALA A 243
ASP A 244
GLY A 352
ILE A 351
VAL A 239
ILE A 241
None
None
None
None
DMS  A 504 ( 4.7A)
None
1.45A 3ndxB-4g09A:
undetectable
3ndxB-4g09A:
12.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hkm ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE


(Xanthomonas
campestris)
PF00591
(Glycos_transf_3)
PF02885
(Glycos_trans_3N)
5 ALA A  60
ILE A  18
GLY A  55
ILE A  54
ILE A 178
None
0.89A 3ndxB-4hkmA:
undetectable
3ndxB-4hkmA:
14.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ilk STARVATION SENSING
PROTEIN RSPB


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 206
ALA A 207
ASP A 208
ILE A 190
ILE A 176
None
0.89A 3ndxB-4ilkA:
undetectable
3ndxB-4ilkA:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k59 RNA BINDING PROTEIN
RSMF


(Pseudomonas
aeruginosa)
PF02599
(CsrA)
6 GLY A   5
ALA A  57
ILE A  41
GLY A  54
ILE A   8
ILE A  63
None
1.24A 3ndxB-4k59A:
undetectable
3ndxB-4k59A:
26.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
RIT  A 500 (-3.2A)
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.3A)
0.51A 3ndxB-4njvA:
20.3
3ndxB-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
ILE A  84
RIT  A 500 (-3.2A)
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-4.3A)
0.38A 3ndxB-4njvA:
20.3
3ndxB-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.3A)
0.72A 3ndxB-4njvA:
20.3
3ndxB-4njvA:
84.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pv4 PROLINE
AMINOPEPTIDASE P II


(Yersinia pestis)
PF00557
(Peptidase_M24)
PF05195
(AMP_N)
5 ARG A 219
GLY A 260
ALA A 259
ASP A 258
ILE A 213
None
None
None
MG  A 501 ( 2.0A)
None
0.85A 3ndxB-4pv4A:
undetectable
3ndxB-4pv4A:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xib E3 UBIQUITIN-PROTEIN
LIGASE MIB1


(Homo sapiens)
PF00569
(ZZ)
PF06701
(MIB_HERC2)
5 GLY A 154
ALA A 155
ASP A 220
GLY A 223
VAL A 207
None
0.89A 3ndxB-4xibA:
undetectable
3ndxB-4xibA:
13.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
7 ARG A  10
ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.60A 3ndxB-4ydfA:
12.5
3ndxB-4ydfA:
32.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
5 ILE A 187
GLY A 205
ILE A 206
VAL A 214
ILE A 249
None
0.74A 3ndxB-4ywlA:
undetectable
3ndxB-4ywlA:
17.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
None
0.80A 3ndxB-5b18A:
18.2
3ndxB-5b18A:
73.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b1q U14 PROTEIN

(Human
betaherpesvirus
6B)
PF04637
(Herpes_pp85)
6 ARG A  83
ALA A  44
ASP A  40
ILE A  38
ILE A  33
ILE A  64
None
1.46A 3ndxB-5b1qA:
undetectable
3ndxB-5b1qA:
11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d01 N-ACETYL-ALPHA-D-GLU
COSAMINYL L-MALATE
SYNTHASE


(Bacillus
subtilis)
PF00534
(Glycos_transf_1)
PF13439
(Glyco_transf_4)
6 ARG A 147
ALA A  93
ILE A  79
GLY A   7
ILE A   6
ILE A 116
None
1.30A 3ndxB-5d01A:
undetectable
3ndxB-5d01A:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g5g PUTATIVE XANTHINE
DEHYDROGENASE YAGT
IRON-SULFUR-BINDING
SUBUNIT


(Escherichia
coli)
PF00111
(Fer2)
PF01799
(Fer2_2)
5 GLY A 211
ALA A 212
ASP A 154
GLY A 159
ILE A 216
None
None
None
FES  A 230 (-4.2A)
None
0.85A 3ndxB-5g5gA:
undetectable
3ndxB-5g5gA:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ip7 DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB11
DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB3


(Saccharomyces
cerevisiae)
PF01000
(RNA_pol_A_bac)
PF01193
(RNA_pol_L)
PF13656
(RNA_pol_L_2)
6 ARG K  47
ALA K  86
ASP K  85
ASP K  82
ILE C 258
ILE K  75
None
1.35A 3ndxB-5ip7K:
undetectable
3ndxB-5ip7K:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nva PUTATIVE
SODIUM:SOLUTE
SYMPORTER


(Proteus
mirabilis)
no annotation 5 ALA A 392
ILE A 344
GLY A 385
ILE A 386
ILE A 159
None
0.90A 3ndxB-5nvaA:
undetectable
3ndxB-5nvaA:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ol2 ELECTRON TRANSFER
FLAVOPROTEIN LARGE
SUBUNIT
ELECTRON TRANSFER
FLAVOPROTEIN SMALL
SUBUNIT


(Clostridioides
difficile)
no annotation 6 ARG A 107
GLY B 121
ALA B 120
ILE B  64
ILE B 117
ILE B 136
None
FAD  B 300 (-3.2A)
FAD  B 300 (-3.0A)
None
None
None
1.37A 3ndxB-5ol2A:
undetectable
3ndxB-5ol2A:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ovk 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE FABG


(Mycolicibacterium
smegmatis)
no annotation 5 GLY A 123
ALA A 124
ILE A 146
GLY A  98
ILE A  99
None
None
None
NDP  A 301 (-4.5A)
NDP  A 301 ( 4.9A)
0.90A 3ndxB-5ovkA:
undetectable
3ndxB-5ovkA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ovl 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE FABG


(Mycolicibacterium
smegmatis)
no annotation 5 GLY A 123
ALA A 124
ILE A 146
GLY A  98
ILE A  99
None
None
NAP  A1001 (-4.6A)
NAP  A1001 (-3.4A)
NAP  A1001 (-4.5A)
0.87A 3ndxB-5ovlA:
undetectable
3ndxB-5ovlA:
20.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
None
0.54A 3ndxB-5t2zA:
19.8
3ndxB-5t2zA:
80.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t8t S-ADENOSYLMETHIONINE
SYNTHASE


(Neisseria
gonorrhoeae)
PF00438
(S-AdoMet_synt_N)
PF02772
(S-AdoMet_synt_M)
PF02773
(S-AdoMet_synt_C)
5 GLY A 388
ALA A 387
ILE A 290
GLY A 294
ILE A 325
None
0.88A 3ndxB-5t8tA:
undetectable
3ndxB-5t8tA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ve3 BPPRF

(Paraburkholderia
phytofirmans)
no annotation 5 GLY B  88
ALA B  89
ASP B  90
VAL B  59
ILE B  80
None
0.84A 3ndxB-5ve3B:
undetectable
3ndxB-5ve3B:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vm2 ALCOHOL
DEHYDROGENASE


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 237
ALA A 238
ASP A 239
VAL A 199
ILE A 173
None
0.82A 3ndxB-5vm2A:
undetectable
3ndxB-5vm2A:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x4r S PROTEIN

(Middle East
respiratory
syndrome-related
coronavirus)
no annotation 5 ALA A  53
ASP A  54
ILE A  48
ILE A 337
ILE A  56
None
0.90A 3ndxB-5x4rA:
undetectable
3ndxB-5x4rA:
14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b5i RETINAL
DEHYDROGENASE 2


(Homo sapiens)
no annotation 6 GLY A 247
ALA A 246
ILE A  40
ILE A 209
VAL A  81
ILE A  77
None
1.02A 3ndxB-6b5iA:
undetectable
3ndxB-6b5iA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bma INDOLE-3-GLYCEROL
PHOSPHATE SYNTHASE


(Campylobacter
jejuni)
no annotation 5 ALA A 237
ASP A 236
ILE A 184
GLY A 186
ILE A  54
None
0.81A 3ndxB-6bmaA:
undetectable
3ndxB-6bmaA:
16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cc2 CELL DIVISION
CONTROL PROTEIN 45
CDC45 PUTATIVE


(Entamoeba
histolytica)
no annotation 6 ALA A 357
ASP A 356
GLY A 362
ILE A 364
VAL A  37
ILE A 206
None
1.48A 3ndxB-6cc2A:
undetectable
3ndxB-6cc2A:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cc2 CELL DIVISION
CONTROL PROTEIN 45
CDC45 PUTATIVE


(Entamoeba
histolytica)
no annotation 6 ALA A 357
ILE A 213
GLY A 362
ILE A 364
VAL A  37
ILE A 206
None
1.37A 3ndxB-6cc2A:
undetectable
3ndxB-6cc2A:
20.59